Projects per year
Personal profile
Area of Expertise
Pre-Clinical Services evaluate new therapies against infections using animal models. These studies are done in collaboration with pharmaceutical and academic researchers, and several of these therapies are now being used clinically to treat patients.
Education/Academic qualification
PhD in Microbiology, University of Alabama
BS in Biology, University of California at Irvine
Fingerprint Dive into the research topics where Jerry Simecka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Mycoplasma pulmonis
Medicine & Life Sciences
Mycoplasma
Medicine & Life Sciences
Lung
Medicine & Life Sciences
Mycoplasma Infections
Medicine & Life Sciences
Respiratory System
Medicine & Life Sciences
Immunization
Medicine & Life Sciences
Antibody Formation
Medicine & Life Sciences
Inbred F344 Rats
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2011 2022
Development and Validation of a Chronic Murine Lung Infection Model with S. Aureus
17/10/19 → 16/10/20
Project: Research
Pre-Clinical Services Agreements
Pre-Clinical Services Funding Pool
1/09/19 → 31/08/20
Project: Research
Development and Validation of a Chronic Murine Lung Infection Model with P. aeruginosa
18/04/19 → 17/04/20
Project: Research
Research Output 1984 2019
1
Citation
(Scopus)
Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells
Shelake, S., Sankpal, U. T., Eslin, D., Bowman, P., Simecka, J., Raut, S. L., Ray, A. & Basha, R. M., 15 Feb 2019, In : Apoptosis. 24, 1-2, p. 21-32 12 p.Research output: Contribution to journal › Article
Ewing's Sarcoma
Vincristine
Cells
Caspase 7
Cell Survival
2
Citations
(Scopus)
Copper-tolfenamic acid: evaluation of stability and anti-cancer activity
Hurtado, M., Sankpal, U. T., Chhabra, J., Brown, D. T., Maram, R., Patel, R., Gurung, R. K., Simecka, J., Holder, A. A. & Basha, R. M., 15 Feb 2019, In : Investigational New Drugs. 37, 1, p. 27-34 8 p.Research output: Contribution to journal › Article
Copper
Neoplasms
Powders
tolfenamic acid
Cell Line
Primary care clinics can be a source of exposure to virulent Clostridium (now Clostridioides) difficile: An environmental screening study of hospitals and clinics in Dallas-Fort Worth region
Simecka, J. W., Fulda, K. G., Pulse, M., Lee, J. H., Vitucci, J., Nguyen, P., Taylor, P., Filipetto, F., Espinoza, A. M. & Sharma, S., 1 Jan 2019, In : PLoS ONE. 14, 8, e0220646.Research output: Contribution to journal › Article
Open Access
Clostridium
Primary Health Care
Screening
Contamination
Pathogens
7
Citations
(Scopus)
Activity of meropenem-vaborbactam against carbapenem- resistant enterobacteriaceae in a murine model of pyelonephritis
Weiss, W. J., Pulse, M. E., Nguyen, P., Peterson, K., Silva, J., Simecka, J. W., Valtierra, D., Sabet, M. & Griffith, D. C., Jan 2018, In : Antimicrobial agents and chemotherapy. 62, 1, e01439.Research output: Contribution to journal › Article
meropenem
Carbapenems
Pyelonephritis
Enterobacteriaceae
Klebsiella pneumoniae
3
Citations
(Scopus)
Interleukin-17A exacerbates disease severity in BALB/c mice susceptible to lung infection with Mycoplasma pulmonis
Mize, M. T., Sun, X. L. & Simecka, J. W., 1 Sep 2018, In : Infection and Immunity. 86, 9, e00292-18.Research output: Contribution to journal › Article
Mycoplasma pulmonis
Interleukin-17
Lung
Mycoplasma Infections
Infection